Epidermolysis bullosa disease activity scoring index (EBDASI) to monitor the effect of rituximab in recalcitrant epidermolysis bullosa acquisita

被引：0
|
作者：
Yang, A. [1 ,2 ]
Kim, M. [1 ,2 ]
Craig, P. [1 ,3 ]
Murrell, D. [1 ,2 ]
机构：
[1] Univ New South Wales, Sydney, NSW, Australia
[2] St George Hosp, Dermatol Dept, Sydney, NSW, Australia
[3] St George Hosp, Gastroenterol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] Responsiveness of the Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) to therapies in epidermolysis bullosa and epidermolysis bullosa acquisita
    Jain, S. V.
    Loh, C. C.
    Harris, A. G.
    Kim, J.
    Su, J. C.
    Daniel, B. S.
    Venugopal, S. S.
    Intong, L. R.
    Law, M. G.
    Murrell, D. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S42 - S42
  • [2] A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBIDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal Involvement
    Yang, Anes
    Kim, Minhee
    Craig, Philip
    Murrell, Dedee F.
    ACTA DERMATOVENEROLOGICA CROATICA, 2018, 26 (04) : 325 - 328
  • [3] A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
    Rogers, Clare L.
    Gibson, Matthew
    Kern, Johannes S.
    Martin, Linda K.
    Robertson, Susan J.
    Daniel, Benjamin S.
    Su, John C.
    Murrell, Oliver G. C.
    Feng, Grant
    Murrell, Dedee F.
    JAAD INTERNATIONAL, 2021, 2 : 134 - 152
  • [4] A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)
    Rogers, C.
    Gibson, M.
    Kern, J. S.
    Martin, L. K.
    Robertson, S. J.
    Su, J. C.
    Daniel, B. S.
    Murrell, D. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S28 - S28
  • [5] A Case of Recalcitrant Epidermolysis Bullosa Acquisita Responsive to Rituximab Therapy
    McKinley, Sophia K.
    Huang, Jennifer T.
    Tan, Jennifer
    Kroshinsky, Daniela
    Gellis, Stephen
    PEDIATRIC DERMATOLOGY, 2014, 31 (02) : 241 - 244
  • [6] Epidermolysis bullosa acquisita treated with rituximab
    Mendes, Sonia Raquel
    Coutinho, Ines
    Cardoso, Jose Carlos
    BMJ CASE REPORTS, 2021, 14 (07)
  • [7] Rituximab in the treatment of epidermolysis bullosa acquisita
    Sami, N
    Elmets, C
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P116 - P116
  • [8] The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa
    Jain, S. V.
    Harris, A. G.
    Su, J. C.
    Orchard, D.
    Warren, L. J.
    McManus, H.
    Murrell, D. F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (04) : 692 - 698
  • [9] Development, reliability and validity of a novel severity score for epidermolysis bullosa: The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)
    Loh, C. C. H.
    Kim, J.
    Su, J. C.
    Daniel, B. S.
    Venugopal, S. S.
    Rhodes, L. M.
    Intong, L. R. A.
    Law, M.
    Murrell, D. F.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 : 47 - 47
  • [10] Efficacy of rituximab in the treatment of epidermolysis bullosa acquisita
    Bratsos, Sosipatros P.
    Demir, Zilan
    Mee, John B.
    Groves, Richard W.
    Tull, Thomas J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 50 (01) : 97 - 103
12345